Tech Company Financing Transactions
Promedior Funding Round
Shire Strategic Investment Group participated in a $3 million Series D funding round for Promedior. The funding round was announced on 10/16/2012.
Transaction Overview
Company Name
Announced On
10/16/2012
Transaction Type
Venture Equity
Amount
$3,000,000
Round
Series D
Investors
Proceeds Purpose
Proceeds from the financing will enable Promedior to broaden and advance its pipeline of Pentraxin-2 therapeutics.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
Promedior is a product-focused biopharmaceutical company developing novel therapeutics for the treatment of fibrotic disorders and diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Russell Ellison
Chief Medical Officer
Bernt Blink
Chief Medical Officer
Renu Gupta
Chief Operating Officer
Richard Jack
VP - Bus. Development
Scott Willett
Browse more venture capital transactions:
Prev: 10/16/2012: TopFloor venture capital transaction
Next: 10/16/2012: Streak venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs